Announcements Trials

Browse Landscape

Status

Completed 30 Recruiting 14 Terminated 6 Unknown 4 Not yet recruiting 4 Active not recruiting 2 No longer available 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 15 Melanoma 14 Carcinoma, Non-Small-Cell Lung 13 Recurrence 12 Neoplasms 12 Leukemia, Myeloid, Acute 9 Glioblastoma 8 Prostatic Neoplasms 6 Lung Neoplasms 6 Breast Neoplasms 6 Lymphoma 5 Glioma 5 Carcinoma, Renal Cell 5 Sarcoma 4 Pancreatic Neoplasms 4 Lymphoma, Non-Hodgkin 4 Gastrointestinal Stromal Tumors 4 Colorectal Neoplasms 4 Triple Negative Breast Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Carcinoma 3 Solid Tumors 2 Small Cell Lung Carcinoma 2 Ovarian Neoplasms 2 Neoplasms by Site 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Large-Cell, Anaplastic 2 Liver Neoplasms 2 Leukemia 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × INDUSTRY × Disease × Clear all

NCT03123952 2019-07-15

Expanded Access to ABT-414

AbbVie

No longer available

Disease, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡